CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gielen, M.
Right arrow Articles by Jack, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gielen, M.
Right arrow Articles by Jack, N.
Canadian Journal of Anesthesia 52:490-492 (2005)
© Canadian Anesthesiologists' Society, 2005

Regional Anesthesia and Pain

Successful defibrillation immediately after the intravascular injection of ropivacaine

[Défibrillation réussie immédiatement après l’injection intravasculaire de ropivacaïne]

Mathieu Gielen, MD PhD*, Robert Slappendel, MD PhD{dagger} and Nigel Jack, MD{dagger}

* From the Departments of Anesthesiology, UMC St. Radboud; and
{dagger} Sint Maartenskliniek, Nijmegen, The Netherlands.

Address correspondence to : Dr. Mathieu Gielen, Department of Anesthesiology, UMC St. Radboud, Postbus 9101, 6500 HB Nijmegen, The Netherlands. E-mail: mat.gielen{at}planet.nl

Purpose: To report successful resuscitation of ventricular fibrillation induced by accidental intravascular injection of ropivacaine.

Clinical features: A 15-yr-old healthy girl weighing 59 kg was scheduled for transposition of the tibial tuberosity under combined sciatic/three-in-one block. No premedication was given. In the induction room, an iv infusion was started, along with electrocardiogram monitoring, non-invasive blood-pressure measurement and pulse-oximetry. The sciatic nerve was found with the use of a nerve stimulator at the first attempt by the classical approach of Labat. Aspiration for blood was negative and the injection of ropivacaine 0.75% without epinephrine started. Convulsions, followed within seconds by ventricular fibrillation occurred at the end of the injection of 18 mL ropivacaine 0.75%. Oxygen was administered by face mask ventilation and immediate defibrillation was successful on the second attempt (2 x 200 joules). Within two minutes convulsions stopped and normal cardiac rhythm returned. Propofol and sufentanil were injected and a laryngeal mask inserted to start general anesthesia for surgery. Postoperatively no evidence of sciatic block could be demonstrated. The patient did not remember the event and was discharged the following day with no residual effects.

Conclusion: This case report shows that ventricular fibrillation after unintentional intravascular injection of ropivacaine can be treated successfully when one is prepared and cardiac life support measures are taken immediately.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. Szabo, N. Szentandrassy, P. Birinyi, B. Horvath, G. Szabo, T. Banyasz, I. Marton, P. P. Nanasi, and J. Magyar
Effects of articaine on action potential characteristics and the underlying ion currents in canine ventricular myocytes
Br. J. Anaesth., November 1, 2007; 99(5): 726 - 733.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
B. T. Finucane
Ropivacaine cardiac toxicity - not as troublesome as bupivacaine/La toxicite cardiaque a la ropivacaine, comparee a la bupivacaine, ne presente pas autant de complications
Can J Anesth, May 1, 2005; 52(5): 449 - 453.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Canadian Anesthesiologists' Society.